CHARMIE FAITH FRYKMAN: Open Payments
NPI 1043093198 · HOLYOKE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,868 in 89 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,868
Food & beverage: $1,789Education: $80
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 35 | $753 |
| Janssen Pharmaceuticals, Inc | 22 | $452 |
| Vanda Pharmaceuticals Inc. | 10 | $158 |
| E.R. Squibb & Sons, L.L.C. | 6 | $111 |
| ABBVIE INC. | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Neurocrine BioSciences, Inc. | 2 | $68 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Alkermes, Inc. | 1 | $26 |
Products named: UZEDY, INVEGA SUSTENNA, AUSTEDO XR, FANAPT, COBENFY, REXULTI, VRAYLAR, CAPLYTA.
Industry payments across MA — which companies pay providers there.
